Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Partner Fera Pharmaceuticals Files Application for Orphan Drug Designation for Naproxcinod in Sickle-Cell Disease

April 2, 2020

View Press Release Corporate presentation Contact us
Previous